Datasets:
timotheeplanes
/
doping

Dataset card Data Studio Files
xet
 Community
1
text
stringlengths
1
17.8k
Metabolite : Any substance produced by a biotransformation process.
Minimum Reporting Level : The estimated concentration of a Prohibited Substance or its Metabolite(s) or Marker(s) in a Sample below which WADA -accredited laboratories should not report that Sample as an Adverse Analytical Finding .
Minor : A natural Person who has not reached the age of eighteen (18) years.
National Anti -Doping Organi sation : The entity(ies) designated by each country as possessing the primary authority and responsibility to adopt and implement anti -doping rules, direct the collection of Samples , manage of test results and conduct Results Management at the national level.
If this designation has not been made by the competent public authority(ies), the entity shall be the country’s National Olympic Committee or its designee.
National Eve nt: A sport Event or Competition involving International - or National -Level Athletes that is not an International Event .
83 [Comment to International -Level Athlete : Consistent with the International Standard for Testing and Investigations, TWIF is free to determine the criteria it will use to classify Athletes as International -Level Athletes, e.g., by ranking, by participation in particul ar International Events, by type of license, etc.
However, it must publish those criteria in clear and concise form, so that Ath letes are able to ascertain quickly and easily when they will become classified as International -Level Athletes.
For example, if the criteria include participation in certain International Events, then the International Federation must publish a list of those Interna tional Events.]
TWIF 2021 Anti -Doping Rules v1 Page 64 of 67 National Federation / Association : A national or regional entity which is a member of or is recogni sed by TWIF as the entity governing TWIF 's sport in that nation or region.
National -Level Athlete : Athletes who compete in sport at the national level, as defined by each National Anti-Doping Organi sation , consistent with the International Standard for Testing and Investigations.
National Olympic Committee : The organi sation recogni sed by the International Olympic Committee.
The term National Olympic Committee shall also include the National Sport Confederation in those countries where the National Sport Confederation assumes typical National Olympic Committee responsibilities in the anti -doping area.
No Fault or Negligence : The Athlete or other Person 's estab lishing that he or she did not know or suspect, and could not reasonably have known or suspected even with the exercise of utmost caution, that he or she had Used or been administered the Prohibited Substance or Prohibited Method or otherwise violated an anti-doping rule .
Except in the case of a Protected Person or Recreational Athlete , for any violation of Article 2.1, the Athlete must also establish how the Prohibited Substance entered the Athlete’s system .
No Significant Fault or Negligence : The Athlete or other Person 's establishing that any Fault or Negligence , when viewed in the totality of the circumstances and taking into account the criteria for No Fault or Negligence , was not significant in relationship to the anti -doping rule violation.
Ex cept in the case of a Protected Person or Recreational Athlete , for any violation of Article 2.1, the Athlete must also establish how the Prohibited Substance entered the Athlete’s system.
Operational Independence : This means that (1) board members, staff members, commission members, consultants and officials of the Anti-Doping Organi sation with responsibility for Results Management or its affiliates (e.g., member federation or confederation), as well as any Person involved in the investigation and pre-adjudication of the matter cannot be appointed as members and/or clerks (to the extent that such clerk is involved in the deliberation process and/or drafting of any decision) of hearing panels of that Anti-Doping Organisation with responsibility for Results Management and (2) hearing panels shall be in a position to conduct the hearing and decision -making process without interference from the Anti-Doping Organi sation or any third party.
The objective is to ensure that members of the hearing panel or individuals otherwise involved in the decision of the hearing panel, are not involved in the investigation of, or decisions to proceed with, the case.
Out-of-Competition : Any period which is not In-Competition .
Participant : Any Athlete or Athlete Support Person .
Person : A natural Person or an organi sation or other entity.
Possession : The actual, physical Possession , or the constructive Possession (which shall be found only if the Person has exclusive control or intends to exercise control over the Prohibited Substance or Prohibited Method or the premises in which a Prohibited Substance or Prohibited Method exists); provided, however, that if the Person does not have exclusive control over the Prohibited Substance or Prohibited Method or the premises in which a Prohibited Substance or Prohibited Method exists, constructive Possession shall only be found if the Person knew about the presence of the Prohibited Substance or Prohibited Method and intended to exercise control over it.
Provided, however, there shall be no anti -doping rule violation based solely on Possession if, prior to receiving notification of any kind that the Person has committed an a nti-doping rule violation, the Person has taken concrete action demonstrating that the Person never intended to have Possession and has renounced Possession by explicitly declaring it to an Anti-Doping Organi sation .
Notwithstanding anything to the contrary in this definition, the purchase (including by any electronic or other means) of a Prohibited Substance or Prohibited Method constitutes Possession by the Person who makes the purchase.84 84 [Comment to Possession : Under this definition, anabolic steroids found in an Athlete's car would constitute a violation unless the Athlete establishes that someone else used the car; in that event, TWIF must establish that, even though the Athlete did not have TWIF 2021 Anti -Doping Rules v1 Page 65 of 67 Prohibited List : The list identifying the Prohibited Substances and Prohibited Methods .
Prohibited Method : Any method so described on the Prohibited List .
Prohibited Substance : Any substance, or class of substances, so described on the Prohibited List .
Protected Person : An Athlete or other natural Person who at the time of the anti -doping rule violation: (i) has not reached the age of sixteen (16) years; (ii) has not reached the age of eighteen (18) years and is not included in any Registered Testing Pool and has never competed in any International Event in an open category; or (iii) for reasons other than age has been determined to lack legal capacity under applicable national legislation.85 Provisional Hearing : For purposes of Article 7.4.3, an expedit ed abbreviated hearing occurring prior to a hearing under Article 8 that provides the Athlete with notice and an opportunity to be heard in either written or oral form.86 Provisional Suspension : See Consequences of Anti -Doping Rule Violations above.
Publicly Disclose : See Consequences of Anti -Doping Rule Violations above.
Recreational Athlete : A natural Person who is so defined by the relevant National Anti -Doping Organi sation ; provided, however, the term shall not include any Person who, within the five (5) years prior to committing any anti -doping rule violation, has been an International -Level Athlete (as defined by each International Federation consistent with the Internati onal Standard for Testing and Investigations) or National -Level Athlete (as defined by each National Anti -Doping Organi sation consistent with the International Standard for Testing and Investigations), has represented any country in an International Event in an open category or has been included within any Registered Testing Pool or other whereabouts information pool maintained by any International Federation or National Anti -Doping Organi sation .87 Regional Anti -Doping Organi sation : A regional entity designated by member countries to coordinate and manage delegated areas of their national anti -doping programs, which may include the adoption and implementation of anti -doping rules, the planning and collection of Samples , the management of results, the review of TUEs , the conduct of hearings, and the conduct of Educational programs at a regional level.
Registered Testing Pool : The pool of highest -priority Athletes established separately at the international level by International Federations and at the national level by National Anti -Doping Organi sations , who are subject to focused In-Competition and Out-of-Competition Testing as part of that International Federati on's or National Anti -Doping Organi sation's test distribution plan and therefore are required to provide exclusive control over the car, the Athlete knew about the anabolic steroids and intended to have control over them.
Similarly, in the example of anabolic steroids found in a home medicine cabinet under the joint control of an Athlete and spouse, TWIF must establish that the Athlete knew the anabolic steroids were in the cabinet and that the Athl ete intended to exercise control over them.
The act of purchasing a Prohibited Substance alone constitutes Possession, even where, for example, the product does no t arrive, is received by someone else, or is sent to a third party address.]
85 [Comment to Protected Person: The Code treats Protected Persons differently than other Athletes or Persons in certain circumstances based on the understanding that, below a certain age or intellectual capacity, an Athlete or other Person may n ot possess th e mental capacity to understand and appreciate the prohibitions against conduct contained in the Code.
This would include, for example, a Paralympic Athlete with a documented lack of legal capacity due to an intellectual impairment.
The te rm “open category ” is meant to exclude competition that is limited to junior or age group categories.]
86 [Comment to Provisional Hearing : A Provisional Hearing is only a preliminary proceeding which may not involve a full review of the facts of the case.
Following a Provisional Hearing, the Athlete remains entitled to a subsequent full hearing on the merits of the case.
By contrast, an “expedited hearing”, as that term is used in Article 7.4.3, is a full hearing on the merits conducted on an expedited time schedule.]
87 [Comment to Recreational Athlete: The term “open category” is meant to exclude competition that is limited to junior or age g roup categories.]
TWIF 2021 Anti -Doping Rules v1 Page 66 of 67 whereabouts information as provided in Article 5.
5 and the International Standard for Testing and Investigations.
Results Management : The process encompassing the timeframe between notification as per Article 5 of the International Standard for Results Management , or in certain cases (e.g., Atypical Finding , Athlete Biological Passport , whereabouts failure), such pre -notification steps expressly provided for in Article 5 of the International Standard for Results Management , through the charge until the final resolution of the matter, including the end of the hearing process at first instance or on app eal (if an appeal was lodged).
Sample or Specimen : Any biological material collected for the purposes of Doping Control .88 Signatories : Those entities accepting the Code and agreeing to implement the Code , as provided in Article 23 of the Code .
Specified Method: See Article 4.2.2.
Specified Substance : See Article 4.2.2.
Strict Liability : The rule which provides that under Article 2.1 and Article 2.2, it is not necessary that intent, Fault , Negligence , or knowing Use on the Athlete’s part be demonstrated by the Anti-Doping Organi sation in order to establish an anti -doping rule violation.
Substance of Abuse : See Article 4.2.3.
Substantial Assistance : For purposes of Article 10.7.1, a Person providing Substantial Assistance must: (1) fully disclose in a signed written statement or recorded interview all information he or she possesses in relation to anti -doping rule violations or other proceeding described in Article 10.7.1.1, and (2) fully cooperate with the investigation a nd adjudication of any case or matter related to that information, including, for example, presenting testimony at a hearing if requested to do so by an Anti-Doping Organi sation or hearing panel.
Further, the information provided must be credible and must comprise an important part of any case or proceeding which is initiated or, if no case or proceeding is initiated, must have provided a sufficient basis on which a case or proceeding could have been brought.
Tampering : Intentional conduct which subverts t he Doping Control process but which would not otherwise be included in the definition of Prohibited Methods .
Tampering shall include, without limitation, offering or accepting a bribe to perform or fail to perform an act, preventing the collection of a Sample , affecting or making impossible the analysis of a Sample , falsifying documents submitted to an Anti-Doping Organi sation or TUE committee or hearing panel, procuring false testimony from witnesses, committing any other fraudulent act upon the Anti-Doping Organi sation or hearing body to affect Results Management or the imposition of Consequences , and any other similar intentional interference or Attempted interference with any aspect of Doping Control .89 Target Testing : Selection of specific Athletes for Testing based on criteria set forth in the International Standard for Testing and Investigations.
Team Sport : A sport in which the substitution of players is permitted during a Competition .
Technical Document : A docum ent adopted and published by WADA from time to time containing mandatory technical requirements on specific anti -doping topics as set forth in an International Standard .
88 [Comment to Sample or Specimen : It has sometimes been claimed that the collection of blood Sa mples violates the tenets of certain religious or cultural groups.
It has been determined that there is no basis for any such claim.]
89 [Comment to Tampering: For example, this Article would prohibit altering identification numbers on a Doping Control form duri ng Testing, breaking the B bottle at the time of B Sample analysis, altering a Sample by the addition of a foreign substance, or intimidating or attempting to intimidate a potential witness or a witness who has provided testimony or information in the Dopi ng Control process.
Tampering includes misconduct which occurs during the Results Management process.
See Article 10.9.3.3.
However , actions taken as part of a Person's legitimate defense to an anti -doping rule violation charge shall not be considered Tampering.
Offensive conduct towards a Doping Control official or other Person involved in Doping Control which does not otherwise cons titute Tampering shall be addressed in the disciplinary rules of sport organisations.]
TWIF 2021 Anti -Doping Rules v1 Page 67 of 67 Testing : The parts of the Doping Control process involving test distribution planning, Sample collection, Sample handling, and Sample transport to the laboratory.
Testing Pool: The tier below the Registered Testing Pool which includes Athletes from whom some whereabouts information is required in order to locate and Test the Athlete Out-of-Competition .
Therapeutic Use Exemption (TUE): A Therapeutic Use Exemption allows an Athlete with a medical condition to Use a Prohibited Substance or Prohibited Method , but only if the conditions set out in Article 4.4 and the International Standard for Therapeutic Use Exemptions are met.
Trafficking : Selling, giving, transporting, sending, delivering or distributing (or Possessing for any such purpose) a Prohibited Substance or Prohibited Method (either physically or by any electronic or other means) by an Athlete , Athlete Support Person or any other Person subject to the authority of an Anti-Doping Organi sation to any third party; provided, however, this definition shall not include the actions of bona fide medical personnel involving a Prohibited Substance Used for genuine and legal therapeutic purp oses or other acceptable justification, and shall not include actions involving Prohibited Substances which are not prohibited in Out-of-Competition Testing unless the circumstances as a whole demonstrate such Prohibited Substances are not intended for gen uine and legal therapeutic purposes or are intended to enhance sport performance.
UNESCO Convention : The International Convention against Doping in Sport adopted by the 33rd session of the UNESCO General Conference on 19 October 2005 including any and all amendments adopted by the States Parties to the Convention and the Conference of Parties to the International Convention against Doping in Sport.
Use: The utili sation, appl ication, ingestion, injection or consumption by any means whatsoever of any Prohibited Substance or Prohibited Method .
WADA : The World Anti -Doping Agency.
Without Prejudice Agreement : For purposes of Articles 10.7.1.1 and 10.8.2, a written agreement between an Anti-Doping Organi sation and an Athlete or other Person that allows the Athlete or other Person to provide information to the Anti-Doping Organi sation in a defined time -limited setting with the understanding that, if an agreement for Substantial Assistance or a case resolution agreement is not finali sed, the information provided by the Athlete or other Person in this particular setting may not be used by the Anti-Doping Organi sation against the Athlete or other Person in any Results Management proceeding under the Code , and that the information provided by the Anti-Doping Organi sation in this particular setting may not be used by the Athlete or other Person against the Anti-Doping Organi sation in any Results Management proceeding under the Code .
Such an agreement shall not preclude the Anti-Doping Organi sation , Athlete or other Person from using any information or evidence gathered from any source other than during the specific time -limited setting described in the agreement.
UCI CYCLING REGULATIONS Page 1 of 70 UCI ADR 2021 PART 14 ANTI -DOPING RULES (“UCI ADR”) Version entering into force on 1 January 2021 UCI CYCLING REGULATIONS Page 2 of 70 UCI ADR 2021 INTRODUCTION ................................ ................................ ................................ ................................ ............................ 5 A.
Preface ................................ ................................ ................................ ................................ ................................ ........ 5 B.
Fundamental Rationale for the Code and these Anti -Doping Rules ................................ ................................ ............. 5 C. Scope of these Anti -Doping Rules ................................ ................................ ................................ ............................... 6 D. International Level Rider s ................................ ................................ ................................ ................................ ............ 7 E. Documents Adopted by the UCI in Connection with these Anti -Doping Rules ................................ .............................. 7 DEFINITION OF DOPING ................................ ................................ ................................ ...................... 8 ANTI -DOPING RULE VIOLATIONS ................................ ................................ ................................ ....... 8 Presence of a Prohibited Substance or its Metabolites or Markers in a Rider’s Sample ................................ ............... 8 Use or Attempted Use by a Rider of a Prohibited Substance or a Prohibited Method ................................ ................... 8 Evading, Refusing or Failing to Submit to Sample Collection by a Rider ................................ ................................ ...... 9 Whereabouts Failures by a Rider ................................ ................................ ................................ ................................ 9 Tampering or Attempted Tampering with any part of Doping Control by a Rider or Other Person ................................ 9 Possession of a Prohibited Substance or a Prohibited Method by a Rider or Rider Support Person ............................ 9 Trafficking or Attempted Trafficking in any Prohibited Substance or Prohibited Method by a Rider or Other Person .. 10 Administration or Attempt ed Administration by a Rider or Other Person to any Rider In -Competition of any Prohibited Substance or Prohibited Method , or Administration or Attempted Administration to any Rider Out -of-Competition of any Prohibited Substance or any Prohibited Method that is Prohibited Out-of-Competition ................................ .......................... 10 Complicity or Attempted Complicity by a Rider or Other Person ................................ ................................ ................ 10 Prohibited Association by a Rider or Other Person ................................ ................................ ............................... 10 Acts by a Rider or Other Person to Discourage or Retaliate Against Reporting to Authorities ............................... 11 PROOF OF DOPING ................................ ................................ ................................ ........................... 12 Burdens and Standards of Proof ................................ ................................ ................................ ................................ 12 Methods of Establishing Facts and Presumptions ................................ ................................ ................................ ...... 12 PROHIBITED LIST AND THERAPEUTIC USE EXEMPTIONS ................................ ............................. 14 Incorporation of the Prohibited List ................................ ................................ ................................ ............................ 14 Prohibited Substances and Prohibited Methods Identified on the Prohibited List ................................ ....................... 14 WADA’s Determination of the Prohibited List ................................ ................................ ................................ ............. 15 Therapeutic Use Exemptions (“TUEs”) ................................ ................................ ................................ ...................... 15 Monitoring Program ................................ ................................ ................................ ................................ ................... 18 TESTING AND INVESTIGATIONS ................................ ................................ ................................ ....... 19 Purpose of Testing and Investigations ................................ ................................ ................................ ....................... 19 Authority to Test ................................ ................................ ................................ ................................ ........................ 19 Event Testing ................................ ................................ ................................ ................................ ............................ 19 Testing Requirements ................................ ................................ ................................ ................................ ............... 20 Rider Whereabouts Information ................................ ................................ ................................ ................................ .
20 Retired Riders Returning to Competition ................................ ................................ ................................ ................... 22 Investigation and Intelligence Gathering ................................ ................................ ................................ .................... 23 Independent Observer Program ................................ ................................ ................................ ................................ 23 ANALYSIS OF SAMPLES ................................ ................................ ................................ .................... 23 Use of Accredited, Approved Laboratories and Other Laboratories ................................ ................................ ........... 23 Purpose of Analysis of Samples and Data ................................ ................................ ................................ ................. 23 Research on Samples and Data ................................ ................................ ................................ ................................ 23 Standards for Sample Analysis and Reporting ................................ ................................ ................................ ........... 24 Further Analysis of a Sample Prior to or During Results Management or Hearing Process ................................ ........ 24 Further Analysis of a Sample After it has been Reported as Negative or has Otherwise not Resulted in an Anti -Doping Rule Violation Charge ................................ ................................ ................................ ................................ ........................... 24 Split of A or B Sample ................................ ................................ ................................ ................................ ............... 24 Ownership of Samples ................................ ................................ ................................ ................................ .............. 25 WADA ’s Right to Take Possession of Samples and Data ................................ ................................ .......................... 25 UCI CYCLING REGULATIONS Page 3 of 70 UCI ADR 2021 Costs of Testing and Analysis ................................ ................................ ................................ .............................. 25 RESULTS MANAGEMENT & INVESTIGATIONS ................................ ................................ ................. 25 Responsibility for Conducting Results Management ................................ ................................ ................................ .. 25 Review and Notification Regarding Potential Anti -Doping Rule Violations ................................ ................................ .. 27 Provisional Suspensions ................................ ................................ ................................ ................................ ........... 27 Results Management Decisions ................................ ................................ ................................ ................................ 27 Notification of Results Management Decisions ................................ ................................ ................................ .......... 28 Retirement from Sport ................................ ................................ ................................ ................................ ............... 28 RESULTS MANAGEMENT : NOTICE OF CHARGE, AGREEMENT, FAILURE TO CHALLENGE AND HEARING PROCESS ................................ ................................ ................................ ................................ ................... 28 Notice of Charge ................................ ................................ ................................ ................................ ....................... 28 Acceptance of Consequences and Failure to Challenge the Anti -Doping Rule Violation ................................ ............ 29 Hearing Process ................................ ................................ ................................ ................................ ........................ 29 Single Hearing Before CAS ................................ ................................ ................................ ................................ ....... 30 Event Hearings ................................ ................................ ................................ ................................ .......................... 30 Waiver of Hearing ................................ ................................ ................................ ................................ ...................... 30 Notice of Decision ................................ ................................ ................................ ................................ ..................... 30 AUTOMATIC DISQUALIFICATION OF INDIVIDUAL RESULTS ................................ ........................... 30 SANCTIONS ON INDIVIDUALS ................................ ................................ ................................ ........... 31 Disqualification of Results in the Event during which an Anti -Doping Rule Violation Occurs ................................ .
31 Ineligibility for Presence, Use or Attempted Use, or Possession of a Prohibited Substance or Prohibited Method 31 Ineligibility for Other Anti-Doping Rule Violations ................................ ................................ ................................ .. 32 Aggravating Circumstances which may Increase the Period of Ineligibility ................................ ............................ 33 Elimination of the Period of Ineligibility where there is No Fault or Negligence ................................ ..................... 34 Reduction of the Period of Ineligibility based on No Significant Fault or Negligence ................................ ................... 34 Elimination, Reduction, or Suspension of Period of Ineligibility or other Consequences for Reasons other than Fault ................................ ................................ ................................ ................................ ................................ ............ 35 Results Management Agreements ................................ ................................ ................................ ....................... 37 Multiple Violations ................................ ................................ ................................ ................................ ................ 38 Disqualification of Results in Competitions Subsequent to Sample Collection or Commission of an Anti -Doping Rule Violation ................................ ................................ ................................ ................................ ................................ ............ 39 Forfeited Prize Money ................................ ................................ ................................ ................................ .......... 40 Financial Consequences ................................ ................................ ................................ ................................ ...... 40 Commencement of Ineligibility Period ................................ ................................ ................................ .................. 41 Status During Ineligibility or Provisional Suspension ................................ ................................ ............................ 42 Automatic Publication of Sanction ................................ ................................ ................................ ........................ 43 CONSEQUENCES TO TEAMS ................................ ................................ ................................ ............ 44 Testing of Teams ................................ ................................ ................................ ................................ ................. 44 Disqualification of Team Competition Results ................................ ................................ ................................ ....... 44 Suspension of a Team Registered with the UCI ................................ ................................ ................................ ... 44 Financial Consequences to Teams ................................ ................................ ................................ ...................... 46 SANCTIONS BY THE UCI AGAINST OTHER SPORTING BODIES ................................ .................... 46 RESULTS MANAGEMENT : APPEALS ................................ ................................ ................................ 46 Decisions Subject to Appeal ................................ ................................ ................................ ................................ .
46 Appeals from Decisions Regarding Anti -Doping Rule Violations, Consequences , Provisional Suspensions, Implementation of Decisions and Authority ................................ ................................ ................................ ........................... 47 Failure to Render a Timely Decision by an Anti-Doping Organization ................................ ................................ ... 50 Appeals Relating to TUEs ................................ ................................ ................................ ................................ .... 50 Notification of Appeal Decision ................................ ................................ ................................ ............................. 50 CONFIDENTIALITY AND REPORTING ................................ ................................ ............................... 50 Notice and Time Limits ................................ ................................ ................................ ................................ ......... 50 UCI CYCLING REGULATIONS Page 4 of 70 UCI ADR 2021 Information Concerning Adverse Analytical Findings , Atypical Findings , and Other Asserted Anti -Doping Rule Violations ................................ ................................ ................................ ................................ ................................ ............ 51 Notice of Anti -Doping Rule Violation or violations of Ineligibility or Provisional Suspension Decisions and Request for Files ................................ ................................ ................................ ................................ ................................ ............ 52 Public Disclosure ................................ ................................ ................................ ................................ .................. 52 Statistical Reporting ................................ ................................ ................................ ................................ ............. 53 Doping Control Information Database and Monitoring of Compliance ................................ ................................ ... 53 Data Privacy ................................ ................................ ................................ ................................ ......................... 54 IMPLEMENTATION OF DECISIONS ................................ ................................ ................................ ... 55 Automatic Binding Effect of Decisions by Signatory Anti-Doping Organizations ................................ .................... 55 Implementation of Other Decisions by Anti-Doping Organizations ................................ ................................ ........ 55 Implementation of Decisions by Body that is not a Signatory ................................ ................................ ................ 56 DOPING CONTROL FOR ANIMALS COMPETING IN SPORT [intentionally omitted] .......................... 56 STATUTE OF LIMITATIONS ................................ ................................ ................................ ................ 56 EDUCATION ................................ ................................ ................................ ................................ ........ 56 Principles ................................ ................................ ................................ ................................ ............................. 56 Educational Course ................................ ................................ ................................ ................................ .............. 56 RESEARCH [Intentionally omitted] ................................ ................................ ................................ ....... 57 ADDITIONAL ROLES AND RESPONSIBILITIES OF SIGN ATORIES AND WADA [Intentionally omitted] ................................ ................................ ................................ ................................ ............................. 57 ADDITIONAL ROLES AND RESPONSIBILITIES OF RIDERS AND OTHER PERSONS ................ 57 Roles and Responsibilities of Riders ................................ ................................ ................................ .................... 57 Roles and Responsibilities of Rider Support Personnel ................................ ................................ ........................ 57 Roles and Responsibilities of Other Persons Subject to these Anti -Doping Rules ................................ ................ 58 Consequence s of Non -Compliance with the Responsibilities of Riders , Riders Support Personnel or Other Persons ................................ ................................ ................................ ................................ ................................ ............ 58 Roles and Responsibilities of National Federations ................................ ................................ .............................. 58 Roles and Responsibilities of Teams ................................ ................................ ................................ .................... 59 INVOLVEMENT OF GOVERNMENTS [Intentionally omitted] ................................ ............................... 60 ACCEPTANCE AND IMPLEMENTATION [Intentionally omitted] ................................ .......................... 60 MONITORING AND ENFORCING COMPLIANCE WITH THE CODE AND UNESCO CONVENTION [Intentionally omitted] ................................ ................................ ................................ ................................ .................... 60 MODIFICATION AND WITHDRAWAL [Intentionally omitted] ................................ ................................ 60 INTERPRETATION OF THESE ANTI -DOPING RULES ................................ ................................ ....... 60 TRANSITIONAL PROVISIONS ................................ ................................ ................................ ............ 60 General Application of these Anti -Doping Rules ................................ ................................ ................................ ... 60 Non-Retroactive except for Articles 10.9.4 and 17 or Unless Principle of “Lex Mitior” Applies ............................... 61 Application to Decisions Rendered Prior to 1 January 2021 ................................ ................................ ................. 61 Multiple Violations Where the First Violation Occurs Prior to 1 January 2021 ................................ ....................... 61 Additional Amendments ................................ ................................ ................................ ................................ ....... 61 Changes to the Prohibited List ................................ ................................ ................................ ............................. 61 APPENDIX 1 DEFINITIONS ................................ ................................ ................................ ................................ 62 UCI CYCLING REGULATIONS Page 5 of 70 UCI ADR 2021 PART 14 ANTI -DOPING RULES INTRODUCTION A.
Preface These Anti -Doping Rules are adopted and implemented in accordance with the UCI's responsibilities under the Code , and in furtherance of UCI's continuing efforts to eradicate doping in sport.
They are intended to implement the 2021 version of the Code , with effect on 1st January 2021, for the sport of cycling.
They form an integral part of the UCI Cycling Regulations (Part 14 Anti-Doping Rules).
These Anti -Doping Rules are sport rules governing the conditions under which sport is played.
Rider s, Rider Support Personnel and other Persons accept these rules as a condition of participation or involvement in cycling and shall be bound by them.
These Anti -Doping Rules are intended to apply autonomously and not by reference to existing law or statutes.
The rules and procedures provided for by these Anti -Doping Rules are sport -specific, aimed at enforcing anti -doping rules in a global and harmonized way and are distinct in nature from criminal and civil proceedings.
They are not intended to be subject to or limited by any national requirements and legal standards applicable to such proceedings, although they are intended to be applied in a manner which respects the principles of proportionality and human rights.
When reviewing the facts and the law of a given case, all courts, arbitral tribunals and other adjudicating bodies should be aware of and respect the distinct nature of these Anti -Doping Rules, which implement the Code , and the fact that these rules represent the consensus of a br oad spectrum of stakeholders around the world as to what is necessary to protect and ensure fair sport.
While retaining its ultimate responsibilities as an Anti-Doping Organization and Signatory of the Code , any Anti-Doping Activities under these Anti -Doping Rules may be delegated by the UCI to a Delegated Third Party.
When the UCI has delegated its responsibilit y to implement all or part of the tasks and activities under the se Anti-Doping Rules to a Delegated Third Party, any referen ce to the UCI in these Rules should be intended as a reference to the Delegated Third Party , where applicable and within the context of the aforementioned delegation.
The UCI shall always remain fully responsible for ensuring that any delegated aspects are performed in compliance with the Code .
Italicized terms used in these Anti -Doping Rules are defined in Appendix 1.
Unless otherwise specified, references to Articles are references to Articles of these Anti -Doping Rules.
B.
Fundamental Rationale for the Code and these Anti -Doping Rules Anti-doping programs are founded on the intrinsic value of sport.
This intrinsic value is often referred to as "the spirit of sport": the ethical pursuit of human excellence through the dedicat ed perfection of each Rider ’s natural talents.
Anti-doping programs seek to protect the health of Rider s and to provide the opportunity for Rider s to pursue human excellence without the Use of Prohibited Substances and Methods .
Anti-doping programs see k to maintain the integrity of sport in terms of respect for rules, other competitors, fair competition, a level playing field, and the value of clean sport to the world.
The spirit of sport is the celebration of the human spirit, body and mind.
It is the essence of Olympism and is reflected in the values we find in and through sport, including: UCI CYCLING REGULATIONS Page 6 of 70 UCI ADR 2021 • Health • Ethics, fair play and honesty • Rider s’ rights as set forth in the Code • Excellence in performance • Character and Education • Fun and joy • Teamwork • Dedication and commitment • Respect for rules and laws • Respect for self and other Participants • Courage • Community and solidarity The spirit of sport is expressed in how we play true.
Doping is fundamentally contrary to the spirit of sport.
C. Scope of these Anti -Doping Rules These Anti -Doping Rules shall apply to: (a) The UCI, including its board members, directors, officers and specified employees, and Delegated Third Parties and their employees, who are involved in any Anti-Doping Activities ; (b) National Fe derations , including their board members, directors, officers and specified employees, and Delegated Third Parties and their employees, who are involved in any Anti-Doping Activities ; (c) the following Rider s, Rider Support Personnel and other Persons : (i) any Licen ce-Holder ; [Comment: a licen ce is required to participate in the sport of cycling governed by the rules of the UCI and the National Federations (Article 1.1.010 of the UCI Cycling Regulations).
However, if a Person participates in the sport of cycling governed by the UCI without being holder of a licen ce as required, he will not escape application of the regulations, including these Anti -Doping Rules.]